Dr. Asha M. Thomas

Michael Bolognese is an Endocrinologist in Bethesda, Maryland. Dr. Bolognese is rated as a Distinguished provider by MediFind in the treatment of Postmenopausal Osteoporosis. His top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Menopause, and Hypoparathyroidism.

Dr. Han Na Kim is a Clinical Associate and part-time Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism. Her clinical practice focuses on metabolic bone disease, including osteoporosis and hyperparathyroidism, as well as diabetes mellitus. She earned her medical degree from the University of Chicago Pritzer School of Medicine, completed her residency in Internal Medicine at New York University, and worked as a hospitalist at University of Pittsburgh Medical Center Presbyterian/Montefiore before pursuing an endocrinology fellowship at Johns Hopkins University School of Medicine. She sees patients at the Johns Hopkins Bayview Metabolic Bone and Osteoporosis Center and Green Spring Station Johns Hopkins Endocrinology Clinic (diabetes and thyroid patients only). Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Postmenopausal Osteoporosis. Her top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Juvenile Primary Osteoporosis, and Hyperparathyroidism.

Dr. Kendall Moseley is the Clinical Director of the Division of Diabetes, Endocrinology & Metabolism, Medical Director of the Johns Hopkins Metabolic Bone & Osteoporosis Center and Co-Director of the Johns Hopkins Multidisciplinary Parathyroid Clinic. Dr. Moseley received her medical degree from Baylor College of Medicine in Houston, TX, followed by internal medicine residency training at the Johns Hopkins Hospital. Upon completion of her endocrinology fellowship at Johns Hopkins, she joined the faculty in the Division of Endocrinology, Diabetes & Metabolism of the Johns Hopkins University School of Medicine. Dr. Moseley has a dynamic clinical practice and collaborations within the institution that focus on metabolic bone diseases, osteoporosis, hyperparathyroidism, vitamin D deficiency, atypical fractures, and skeletal survivorship. She is actively engaged in NIH-funded clinical and translational research involving the relationship between type 2 diabetes, osteoporosis, and aging. She is additionally involved in research investigating mechanisms by which chronic disease states such as malignancy, HIV, hepatitis C, and cystic fibrosis impact bone quantity and quality. Clinically, she enjoys partnering with her patients and using their unique and often complex medical history to individually tailor effective diet, lifestyle, and treatment regimens to improve skeletal health. Dr. Moseley is rated as a Distinguished provider by MediFind in the treatment of Postmenopausal Osteoporosis. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Paget's Disease of Bone, and Hyperparathyroidism.